Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.7392
-0.0175 (-2.31%)
At close: Nov 18, 2026, 4:00 PM EST
0.7490
+0.0098 (1.33%)
After-hours: Nov 18, 2026, 7:56 PM EST
Ocugen Market Cap
Ocugen has a market cap or net worth of $250.82 million as of November 18, 2026. It is the 18,733rd most valuable company in the world and the 3,291st biggest in the United States. Its market cap has decreased by 30.77% in one year.
Market Cap
250.82M
Enterprise Value
255.12M
1-Year Change
-30.77%
Global Rank
Country Rank
#3,291 United States
Category
ChartMarket Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $250.82M, an increase of 665.86%. That is a compound annual growth rate of 33.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 250.82M | -40.51% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 261.98M |
| Lexeo Therapeutics | 257.61M |
| Turn Therapeutics | 255.59M |
| Inovio Pharmaceuticals | 255.09M |
| Protalix BioTherapeutics | 252.11M |
| Q32 Bio | 251.06M |
| Camp4 Therapeutics | 251.02M |
| Cabaletta Bio | 248.08M |